What is Ipamorelin? A plain-English explainer
A lab-made pentapeptide from the growth-hormone-releasing-peptide family, sold and studied as a research chemical rather than an approved medicine.
Ipamorelin is a synthetic peptide — a chain of just 5 amino acids — that belongs to a research class called growth-hormone-releasing peptides, or GHRPs. It is sold and studied as a research chemical, not an approved medicine, and there is no FDA-approved prescription form of it. It was first developed by Novo Nordisk in the late 1990s.
That one paragraph is the whole definition. The rest of this page unpacks it at two levels — plain English, then a little deeper — and shows how the reconstitution math works, because Ipamorelin, like most research peptides, ships as a dried powder that has to be mixed and measured before anything else.
Ipamorelin in plain English
Ipamorelin is only 5 amino acids long, which makes it a pentapeptide — one of the shorter peptides that gets studied.
Its sequence isn’t made entirely of the standard 20 amino acids found in food and the human body. It also includes a couple of modified and mirror-image (“D-”) amino acid residues, which is a common design choice in synthetic peptide chemistry — it changes how quickly the molecule breaks down once it’s in solution or in the body, compared to an all-natural sequence.
It usually arrives as a small glass vial of white powder. The powder is the peptide with the water removed (freeze-dried, or “lyophilised”) so it stays stable in storage. On its own, the powder can’t be measured into a syringe — there’s no volume to draw. That’s why the next step, reconstitution, exists.
The science, a little deeper
A few specifics that the plain-English version glosses over:
- It’s a defined 5-amino-acid sequence, written as Aib-His-D-2Nal-D-Phe-Lys-NH2. Aib (alpha-aminoisobutyric acid) and the two D-amino acid residues are not part of the standard set of 20 amino acids the body normally uses to build proteins — they were substituted in deliberately during synthesis.
- It belongs to the GHRP family. Growth-hormone-releasing peptides are a group of research compounds studied for their interaction with the ghrelin receptor (GHS-R1a) in the pituitary gland, a receptor distinct from the one used by the body’s own growth-hormone-releasing hormone.
- “Research chemical” is a regulatory status, not a marketing word. Ipamorelin has not been approved as a drug for any condition. Much of what’s published about it is preclinical — laboratory and animal studies — and this page makes no claim about what it does in people.
If you want the classification in one line: Ipamorelin is a synthetic research pentapeptide, 5 amino acids, member of the GHRP class, supplied as a freeze-dried powder for reconstitution.
How reconstitution works for Ipamorelin
Reconstitution is dissolving the powder in a known volume of liquid so you have a concentration — milligrams of peptide per millilitre of solution. Once the concentration is fixed, the volume you draw for any target amount is simple arithmetic:
- Concentration = vial amount (mg) ÷ diluent volume (mL)
- Draw volume = target amount ÷ concentration
- Syringe units = draw volume (mL) × the units-per-mL of your syringe
The numbers all come from your own vial label and your own paperwork — the peptide amount printed on the vial, the volume of bacteriostatic water you add, and the target amount you were told to use. The separate Amidra web calculator runs exactly those three steps and shows the formula at each one, so you can check it by hand. It never fills in a number for you.
What Amidra does — and doesn’t — do here
Amidra is a tracking and education tool. It converts the values you enter and helps you keep a protocol organised; it does not recommend a dose, a compound, or a schedule, and it takes no position on whether anyone should use Ipamorelin. Those decisions belong with a qualified healthcare professional. The information above is definitional — what the compound is — not medical advice.